Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet
|
|
- Valerie Green
- 5 years ago
- Views:
Transcription
1 1 Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Name of Guideline / Policy/ Procedure MANAGEMENT OF ACUTE PAEDIATRIC ASTHMA Purpose of Procedure/ Guidelines/ Protocol: 3 Replaces: Previous guideline/management (NICE) 4 Professionals consulted during development Prepared by: M Smith Checked by: R. Clements Review date: November Applicable to which staff: 6 Name & Title of Author: Dr M Smith, Consultant Paediatrician Dr Aljarad, CD, Consultant Paediatrician 7 Proposals for dissemination: Southern Trust Web Portal 8 Proposals for implementation: n/a 9 Training Implications: n/a 10 Date Procedure/Guideline/ Protocol submitted to Procedures Committee: 11 Outcome : Approved Approved/Minor amendments Not approved Deferred 12 Date of CYP SMT approval Comments: CYP Clinical Governance Oversight Committee 13 Date of approval by Trust SMT (if n/a required): 14 Date for further review (3 year November 2018 default) 15 Date added to repository: 16 Clinical Guidelines ID: CG0528 (Note: Guideline author to complete parts 1-10)
2 2 MANAGEMENT OF ACUTE PAEDIATRIC ASTHMA Version 09 November 2016 Exacerbation of Asthma Early warning score > 94% OR signs of mild to moderate asthma 4-10 puffs salbutamol (MDI + spacer) up to 3 times. Reassess. BETTER NO BETTER Sp02 on arrival (in room air) SpO2 <94% indication for O2 in acute asthma SpO2 < 92% post bronchodilator = admit BETTER < 94% OR signs of moderate to severe asthma Nebulised salbutamol + Ipratropium bromide + MgSO4 x3 followed by continuous salbutamol nebulization O 2 to keep saturation 94% Oral steroids (if vomiting IV) NO BETTER Clinically improved a) Discharge Education on use of 2 agonist Oral corticosteroid therapy (add early) Consider increased preventive therapy b) Written action plan and letter to GP c) Check inhaler technique d) Follow-up GP or refer to asthma clinic e) No CXR or antibiotic required unless clinically indicated Slow or moderate response a) Admit b) give 3 X nebulized salbutamol/ipratropium bromide immediately in first 60 min (if not given already) thereafter ONLY nebulized salbutamol every 1-4 hours c) Frequent assessment over 6-12 hours d) No CXR or antibiotic required unless clinically indicated Severe life threatening asthma or no response (involve senior clinician or PICU team) Give continuous nebulized bronchodilators Consider: a) IV MgSO4 (avoid in <2 y) or b) IV Salbutamol or c) IV Aminophylline and d) CXR e) Venous blood gas f) Electrolyte levels High dependency care and consider transfer to PICU if child seriously ill or requiring both IV salbutamol and IV aminophylline
3 3 Pharmacotherapy of acute asthma (This should be read in conjunction with BTS Guidelines for the management of acute asthma and current BNF for Children) 2 Agonist Bronchodilators Individualise drug dosing according to severity and adjust according to the patient s response Salbutamol 100 microgram/dose MDI inhaler + spacer device 4 puffs (400 micrograms) repeated every minutes according to clinical response might be sufficient for mild attacks although up to 10 puffs (1000 micrograms) might be needed for more severe asthma. Doses can be repeated every minutes. For patients with moderate to severe asthma, use nebulised 2 agonists with oxygen (2.5-5mg salbutamol). Ipratroprium bromide If symptoms are refractory to initial 2 agonist treatment, add ipratropium bromide ( microgram ( 5yrs)/dose mixed with the nebulised 2 agonist solution) in back to back treatment. Frequent doses up to every minutes ( microgram/dose mixed with the 2 agonist solution (5mg salbutamol neb) in the same nebulizer) should be used early. The dose frequency should be reduced as clinical improvement occurs. There is NO benefit given after 1-2 hours of initial therapy. Nebulised Magnesium sulphate Consider adding 150mg of magnesium sulphate to each nebulized salbutamol/ipratropium in the first hour in children with short duration of acute severe asthma symptoms presenting with an oxygen saturation < 92% Steroid Therapy Give prednisolone early in the treatment of acute asthma attack Use a dose of 20mg for children 2-5 years and 30-40mg for children > 5 years. Those already receiving maintenance steroid tablets should receive 2mg/kg prednisolone up to a maximum dose of 60mg. Use a dose of 10mg of soluble prednisolone for children below 2 years for up to three days. Treatment for up to three days is usually sufficient, but the length of course should be tailored to the number of days necessary to bring about recovery. Dose of IV hydrocortisone 4mg/kg- 6 hourly
4 4 Intravenous therapy 1. IV Magnesium in children with severe / life threatening asthma Use Prescribing Form Dose In children of 5 years and over who have been assessed by the pathway as having severe/life threatening asthma and who do not improve after 3 nebulised treatments. All children who receive intravenous magnesium sulphate must be admitted. Intravenous magnesium sulphate must be prescribed by, or under the supervision of, appropriately experienced Medical, A&E or PICU staff (middle grade staff should always be involved with these children). Magnesium sulphate 50% injection containing 500mg/ml of magnesium sulphate (2mmol/ml of magnesium). This is available in 10ml ampoules. Infuse 40mg/kg (0.16mmol/kg) over 20 minutes. The maximum dose is 2g (8mmol). Use the appropriate volume of magnesium sulphate 500mg/ml (2mmol/ml) from the table below and make up to 20ml with sodium chloride 0.9%. Prepare and use immediately. Administer via an infusion pump. Dose Weight (kg) Dose of magnesium sulphate (mg)(mmol) Dose Volume of 50% magnesium sulphate (ml) 15-16kg 600mg (2.4mmol) 1.2ml 17-18kg 700mg (2.8mmol) 1.4ml 19-23kg 800mg (3.2mmol) 1.6ml 24-28kg 1000mg (4mmol) 2ml 29-33kg 1200mg (4.8mmol) 2.4ml 34-38kg 1400mg (5.6mmol) 2.8ml 39-43kg 1600mg (6.4mmol) 3.2ml 44-48kg 1800mg (7.2mmol) 3.6ml 49kg 2000mg (8mmol) 4ml Contraindications Side Effects Children less than 2 years of age Children with severe renal impairment Children with myasthenia gravis Mild discomfort has been reported at the infusion site during the infusion in approximately half of patients. This is not usually an indication to stop the infusion. A clinically non-significant fall in blood pressure (~5mmHg) may occur. This is not usually an indication to stop the infusion. Overdose Hypermagnesaemia. Dependent on the size of the overdose, progressive muscle weakness, significant hypotension and ultimately respiratory failure have been reported. Repeat doses The clinical state of the patient should be reviewed 20 minutes after the magnesium sulphate infusion is completed. IV magnesium sulphate should NOT be repeated (except by PICU team). If the patient fails to improve, further intravenous therapy with aminophylline/salbutamol should be considered see asthma pathway.
5 5 2. IV Salbutamol in children with severe/ life threatening asthma Involve senior clinician and PICU team Salbutamol 5ml ampoules contain 5mg (1mg/ml) DOSAGE FOR A SINGLE BOLUS By intravenous injection over 5 minutes Child 1 month 2 years 5 micrograms/kg as a single dose Child 2 17 years 15 micrograms/kg (max. 250 micrograms) as a single dose This may be followed up with a continuous infusion in refractory asthma DOSAGE FOR CONTINUOUS INFUSION SEE TABLE Child 1 month 18 years micrograms/kg/hour, dose adjusted according to response and heart rate (doses above 120 micrograms/kg/hour with close monitoring) SALBUTAMOL INFUSION - FOR USE IN PERIPHERAL OR CENTRAL LINE PREPARATION 1. A 50ml bag of NaCl 0.9% should be used. 2. Withdraw 10ml from the bag. 3. Add 10ml (10 mg) of salbutamol for intravenous infusion (two 5ml ampoules) 4. This will produce a final concentration of 200 micrograms per ml 5. More than one 50ml bag can be made up and kept in the fridge 6. Discard 24 hours after preparation. INFUSION RATE PRESCRIPTION TO CALCULATE INFUSION RATE 60 micrograms/kg/hour 0.3ml x wt (kg) per hour 120 micrograms/kg/hour 0.6ml x wt(kg) per hour 180 micrograms/kg/hour 0.9ml x wt(kg) per hour 240 micrograms/kg/hour 1.2ml x wt(kg) per hour 300 micrograms/kg/hour 1.5ml x wt(kg) per hour MONITORING Patients on intravenous salbutamol should have continuous ECG monitoring linked to the central station. Reduce infusion rate if arrhythmia occurs. Serum potassium should be checked 6 hours after commencing infusion and at least 12 hourly thereafter If salbutamol infusion is running for more than 24 hours check serum phosphate and blood sugar.
6 6 3. IV Aminophylline in children with severe/ life threatening asthma Packaging Aminophylline 250mg/10ml solution for injection, ampoules. PREPARATION 1. A 500ml bag of 0.9% Sodium chloride should be used 2. Withdraw 20ml of 0.9% sodium chloride and add 20ml (500mg) of Aminophylline for intravenous infusion (two 10ml ampoules) 3. This will produce a final concentration of 1mg per ml This is a two stage procedure with both loading and maintenance are given in separate syringes First, prepare and label the LOADING dose syringe Give 5mg/kg over 20 minutes - (if on theophylline, commence maintenance only) Calculation:- e.g., for 20kg child, dose is 100mg=100ml. Therefore, give 100ml over 20 minutes = 300ml per hour. Draw up required amount for loading dose from 500ml bag in a syringe and administer first over 20 minutes. Dilute and give slowly over at least 20 minutes, using an infusion pump, at a rate not exceeding 25mg per minute. If acute adverse effects occur, slow the rate or stop the infusion for 5-10 minutes Discard syringe. Second, prepare and label the MAINTENANCE INFUSION using a separate syringe Maintenance dose by continuous IV infusion: CHILD 1 month 12 years Dilute and administer using an infusion pump at an initial rate of 1mg/kg/hour. CHILD years Dilute and administer using an infusion pump at an initial rate of micrograms/kg/hour Age: 1-9 years - 1 mg/kg/hour Age: 9-16 years 800 microgram/kg/hr Calculation: e.g. for 20kg child, dose is 20mg=20ml. Therefore, give 20mls per hour. Do not mix with IV salbutamol Monitor blood glucose and potassium. Patients should have continuous ECG monitoring linked to the central station. If aminophylline is given intravenously, a blood sample should be taken 4-6 hours after starting treatment; in a child already taking theophylline, plasma-theophylline concentration should be determined before giving the intravenous dose. Prepared by: M Smith Checked by: R. Clements Review date: November 2018 References: 1. SIGN 153 British guideline on the management of asthma, A national clinical guideline September 2016 ( 2. BNFC on line ( 3. Medicines for Children 2003, Royal College of Paediatrics and Child Health/NPPG. 4. Medusa ( Accesed 17/11/16.
A Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children
For Use in: By: For: Division responsible for document: Key words: Name and job titles of document author: Name and job title of document author s Line Manager: Supported by: Assessed and approved by the:
More informationManagement of acute asthma in children in emergency department. Moderate asthma
152 Moderate asthma SpO2 92% No clinical features of severe asthma NB: If a patient has signs and symptoms across categories, always treat according to their most severe features agonist 2-10 puffs via
More informationType: Clinical Guideline Register No: Status: Public MANAGEMENT OF ACUTE ASTHMA IN CHILDREN MORE THAN 2 YEARS IN HOSPITAL
MANAGEMENT OF ACUTE ASTHMA IN CHILDREN MORE THAN 2 YEARS IN HOSPITAL Type: Clinical Guideline Register No: 09055 Status: Public Developed in Response to: Best practice CQC Fundamental Standard: 9, 12,
More informationTitle Protocol for the Management of Asthma
Document Control Title Protocol for the Management of Asthma Author Author s job title Professional Lead, Minor Injuries Unit Directorate Emergency Services, Logistics and Resilience Department Version
More informationManagement of acute severe asthma in adults in general practice. Moderate asthma Acute severe asthma Life-threatening asthma INITIAL ASSESSMENT
British guideline on the management of asthma Annex 2 Management of acute severe asthma in adults in general practice Many deaths from asthma are preventable. Delay can be fatal. Factors leading to poor
More informationPrinted copies of this document may not be up to date, obtain the most recent version from
Children s Acute Transport Service Clinical Guidelines Acute Severe Asthma Document Control Information Author E Randle Author Position CATS Consultant Document Owner E Polke Document Owner Position Co-ordinator
More informationLRI Children s Hospital
LRI Children s Hospital Asthma Management in Children On-going Care after Admission to Ward Staff relevant to: Medical & Nursing staff providing asthma management care to Children within UHL Children s
More information(PLACE PATIENT LABEL HERE) Date: Time: Assessment nurse: Sign: STOP!
ASTHMA BEST CARE BUNDLE P A T H W A Y ADULT ASTHMA Date: Time: Assessment nurse: Sign: INCLUSION CRITERIA Known asthmatic Shortness of breath and / or wheeze EXCLUSION CRITERIA Chronic lung disease other
More informationAsthma/wheeze management plan
Asthma/wheeze management plan Name of Patient Date of Birth NHS Number GP surgery Telephone Next appointment Children s Assessment unit/ward telephone Out of hours call 111 Open access Y/N Until date Some
More informationSample. Affix patient label within this box.
Instructions for completing orders Complete pages 1-3 for General Inpatient Orders. All pathway compatible orders (indicated by ) within the General Inpatient Orders will be followed automatically. Optional
More informationClinical guideline for acute wheeze & asthma in children 5 years and over Hospital care
Clinical guideline for acute wheeze & asthma in children years and over Hospital care Airedale NHS Trust Bradford Teaching Hospitals NHS Foundation Trust NHS Bradford and Airedale DOB: A&E/Hospital : Weight:
More informationResuscitation Fluids
Resuscitation Fluids Acceptable Fluids (also known as): Sodium Chloride Hartmann s Solution (Ringer-Lactate Solution, Compound Sodium Lactate) 4.5% Albumin Solution (PPS) Gelofusine 20ml/kg Bolus Can be
More informationNEBULISERS AND NEBULISED MEDICATION. A Guide for the use of nebulisers and nebulised medication in the community setting
NEBULISERS AND NEBULISED MEDICATION A Guide for the use of nebulisers and nebulised medication in the community setting Aim This guide has been developed from the generic guidance circulated in April 2014.
More informationβ 2004 2004 o β β β β 2004 β β β β β β β β β 2004 2004 2004 2004 2004 β 2004 2004 2004 2004 β β 2004 β β β β β β β 2004 β β β β β β 2004 β β β β STEP 5: CONTINUOUS OR FREQUENT USE OF ORAL
More informationEmergency Department Protocol Initiative
Emergency Department Protocol Initiative ACUTE ASTHMA MANAGEMENT TOOLKIT March 2006 Provincial Emergency Services Project PHYSICIAN ORDER TEMPLATE FOR CTAS LEVEL 1 ASTHMA ADULT PEDIATRIC Date: Site: Arrival
More informationEmergency Asthma Care
Emergency Asthma Care Contents Introduction 3 Why good emergency asthma care is important 4 Access to emergency asthma care 5 How to improve emergency asthma care 6 Developing emergency asthma treatment
More informationCardiac Catheter Labs Intravenous Drug Therapy Guide
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab
More informationPatient Profile. Patient s details Initials: IF Age: 40 Gender: Male. Weight: 139.7kg Height: 510 metres BMI: >47
Patient Profile Patient background and medication list Reason for selecting profile Interesting depression case whereby there were several opportunities for intervention as a pharmacist to ensure drug-related
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationA NEBULISERS AND NEBULISED MEDICATION. Generic Guide for the use of nebulisers and nebulised medication
A NEBULISERS AND NEBULISED MEDICATION Generic Guide for the use of nebulisers and nebulised medication Aim The aim of this guide is to provide a template for those who wish to develop their own nebuliser
More informationPAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain
Index No: MMG43 PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Version: 3.1 (Includes anti-emetics and naloxone) Date ratified: July 2013 Ratified by: (Name of Committee) Name
More informationAT TRIAGE. Alberta Acute Childhood Asthma Pathway: Evidence based* recommendations For Emergency / Urgent Care
1 1 Should the child be placed into the Pathway? Asthma Clinical Score (PRAM) Inclusion Children 1 year and 18 years of age who present with wheezing and respiratory distress, and have been diagnosed by
More informationManagement of Acute Asthma Exacerbations in Children 2012 Update. Sharon Kling Dept Paediatrics & Child Health University of Stellenbosch
Management of Acute Asthma Exacerbations in Children 2012 Update Sharon Kling Dept Paediatrics & Child Health University of Stellenbosch Acknowledgements BTS/SIGN guidelines GINA guidelines NAEPP guidelines
More informationSample. Affix patient label within this box.
Instructions for completing orders: Determine PRAM Clinical Score as per the Alberta Acute Childhood Asthma Pathway for Emergent/Urgent Care and select orders based on PRAM Score. Custom orders can be
More informationPEDIATRIC ACUTE ASTHMA SCORE (P.A.A.S.) GUIDELINES. >97% 94% to 96% 91%-93% <90% Moderate to severe expiratory wheeze
Inclusion: Children experiencing acute asthma exacerbation 24 months to 18 years of age with a diagnosis of asthma Patients with a previous history of asthma (Consider differential diagnosis for infants
More informationSeptember 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart
September 14 V0.17 Aims and outcomes of session. Aim: To provide guidance on correctly completing the paediatric daily fluid prescription & balance chart. Outcomes: Demonstrate the ability to: calculate
More informationRecurrent wheezing illnesses 24.9% Similar to Australia Above global averages
Prof Mike South Department of General Medicine Royal Children s Hospital Melbourne Australia www.mikesouth.org.au Asthma is very common in Australia Approx 25% children have recurrent wheezing illnesses
More informationRespiratory system. 1. Asthma acute exacerbations. Contents:
Respiratory system Medicines Formulary Contents: 1. Asthma acute exacerbations 1 2. Asthma chronic 4 3. Chronic obstructive pulmonary disease acute exacerbations 5 4. Chronic obstructive pulmonary disease
More informationNHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults
NHS Grampian Staff Guideline for the Management of Acute Hypokalaemia in Adults Co-ordinators: Medicines Information Pharmacist Consultation Group: See relevant page in guidance Approver: Medicine Guidelines
More informationDrugs acting on the respiratory tract
Drugs acting on the respiratory tract Antiasthmatic drugs Asthma Asthma is a chronic inflammatory disease characterized by episodes of reversible airways obstruction due to bronchial hyperresponsiveness;
More informationDOCUMENT CONTROL PAGE
DOCUMENT CONTROL PAGE Title Title: UNDERGOING SPINAL DEFORMITY SURGERY Version: 2 Reference Number: Supersedes Supersedes: all other versions Description of Amendment(s): Revision of analgesia requirements
More informationADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.
ADULT ASTHMA GUIDE SUMMARY This summary provides busy health professionals with key guidance for assessing and treating adult asthma. Its source document Asthma and Respiratory Foundation NZ Adult Asthma
More informationMedicine Dr. Kawa Lecture 4 - Treatment of asthma :
Medicine Dr. Kawa Lecture 4 - Treatment of asthma : Avoiding allergens. Hyposensitization :Subcutaneous injections of inially very small, but gradually increasing doses of allergens (desensitization or
More informationCLINICAL GUIDELINES ID TAG
CLINICAL GUIDELINES ID TAG Title: Treatment of Hypomagnesaemia in adults Author: Speciality / Division: Directorate: Dr Peter Sharpe, Dr Neal Morgan, Jillian Redpath Chemical Pathology/Nephrology/Pharmacy
More informationDeveloped By Name Signature Date
Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) Salbutamol Aerosol Inhaler and salbutamol Nebulised Solution Trust Ref No 1569-34313 Local Ref (optional) Main points the document Treatment of acute
More informationNeonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick Neonatal Pharmacist
CLINICAL GUIDELINES ID TAG Title: Author: Designation: Speciality / Division: Directorate: Neonatal Parenteral Nutrition Guideline Dr M Hogan, Maire Cullen ANNP, Una Toland Ward Manager, Sandra Kilpatrick
More information500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device
3.1 BRONCHODILATORS 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol Terbutaline 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated e.g. Easi-Breathe 200 micrograms/dose
More informationBNF CHAPTER 3: RESPIRATORY
3.1 BRONCHODILATORS BNF CHAPTER 3: RESPIRATORY 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated (e.g., Easi-Breathe
More informationCommon Infusions for Neonatal Use
Common Infusions for Neonatal Use Document Title and Reference : Common Infusions for Neonatal Use Main Author (s) Dr N B Soni Ratified by: LSC CEG Date Ratified: May 2016 Review Date: May 2018 Version:
More informationDRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy)
DRUG GUIDELINE HYDRALAZINE (Intravenous severe hypertension SCOPE (Area): FOR USE IN: Labour Ward, HDU, Theatre and ED EXCLUSIONS: Paediatrics (seek Paediatrician advice) and other general wards. SCOPE
More informationbeclometasone 100 MDI 2 puffs twice a day (recently changed to non CFC (Clenil Modulite))
Case 1 Mr Thomson, a 32 year old asthmatic who is well known to you comes into your pharmacy. He is known to have a best peak flow of 640 L/min. He tells you that over the last few weeks he has been wakening
More informationDose. Route. Units. Given. Dose. Route. Units. Given
Chapter 4 Respiratory Andrew Stanton SALBUTAMOL (in acute asthma) 5 in acute asthma Nebulised (driven by oxygen not air) 4 6 hourly In acute severe asthma not responding to initial treatment or in life-threatening
More informationADENOSINE. ADRENALINE (Epinephrine)
ADENOSINE Notes Arrhythmias I.V. Initial dose 150 micrograms/kg stat Increase dose if required by 50 micrograms/kg to a maximum of 300 micrograms/kg (or 500 micrograms/kg if over 28 days old) ADMINISTRATION
More informationconcentrate intravenous solution and other strong potassium solutions
Policy for the use of potassium chloride concentrate intravenous solution and other strong potassium solutions CLINICAL GUIDELINES ID TAG Policy for the use of potassium chloride Title: concentrate intravenous
More informationCHARM ASTHMA TREATMENT GUIDELINE
NHS City and Hackney Prescribing Guidelines Adults ( 12 years of age) CHARM ASTHMA TREATMENT GUIDELINE Written by: Hetal Dhruve (Specialist Respiratory Pharmacist, City and Hackney CCG) Checked by: Prof
More informationManaging Exacerbations of COPD (Version 3.0)
Managing Exacerbations of COPD (Version 3.0) Guideline Readership This guideline is intended for use in patients with a confirmed diagnosis of a chronic obstructive pulmonary disease (COPD) exacerbation.
More informationChildren & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet
Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1. Name of Guideline / Policy/ Procedure 2. Purpose of Procedure/ Guidelines/ Protocol Guideline for
More informationNEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES
WOMEN AND NEWBORN HEALTH SERVICE King Edward Memorial Hospital NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES Transport Medication List Title of policy: Transport Medication List Date Revised:
More informationREVIEW AMINOPHYLLINE. Background
REVIEW AMINOPHYLLINE Background The current 13 th edition of the WHO Model Essential Medicines List (dated April 2003) includes aminophylline on the Complementary List. The listing is as shown below (together
More informationPosition within the Organisation
ASTHMA TREATMENT GUIDELINES Document Description Document Type Service Application Guidelines All healthcare professionals(hcps) caring for patients with asthma Version 4.0 Ratification date September
More informationSalapin: Salbutamol BP 2mg as sulphate in each 5mL of a raspberry cola flavoured, sugar free syrup.
Salapin Salbutamol Syrup 2mg/5mL Qualitative and quantitative composition Salapin: Salbutamol BP 2mg as sulphate in each 5mL of a raspberry cola flavoured, sugar free syrup. Clinical particulars Therapeutic
More informationTrust Guideline. for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis. (*ie aged 16 years and over)
Trust Guideline for Ciclosporin Treatment & Monitoring for Adult* Patients with Acute, Severe Ulcerative Colitis (*ie aged 16 years and over) abc A guideline recommended for use In: Gastroenterology/Medical
More informationcontrol in the lowest dose providing adequate Maintain high dose ICS Use daily steroid tablet dose Consider trials of: Increasing ICS up to
Summary of management in adults sthma - suspected dult asthma - diagnosed Diagnosis and ssessment Evaluation: assess symptoms, measure lung function, check inhaler technique and adherence adjust dose update
More informationAcute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)
Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a) Introduction The majority of acute painful crises in patients with sickle cell disease will be managed independently
More informationPaediatric Prescribing Pocket Guide September 2014 (Version 1)
PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors
More informationPaediatric Emergency Prompt Cards
Paediatric Emergency Prompt Cards Introduced July 2016 Prompt cards are designed to be used by any member of the resus team If you have any comments or suggestions, please contact helen.collyer-merritt@sash.nhs.uk
More informationNHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults. Consultation Group: See Page 4. Review Date: June 2021
NHS...... Grampian NHS Grampian Staff Guidance For The Management Of Hypomagnesaemia In Adults Co-ordinators: Consultation Group: Approver:. Senior Medicines Information Pharmacist See Page 4 Medicine
More informationTHEOPHYLLINE WITH INHALED CORTICOSTEROIDS (TWICS) TRIAL SELF MANAGMENT / ACTION PLANS GENUAIR INHALERS: POTENTIAL SAFETY ISSUE
I S S U E 4 M A R C H / A R P I L 2 0 1 6 Endorsed December 2014 I N S I D E T H I S I S S U E : Theophylline with Inhaled Corticosteroids (TWICS) Trial Genuair Inhaler: Potential Safety Issue 1 Self Management
More informationGuideline for the use of Clonidine for Sedation in Adult Intensive Care
Guideline for the use of Clonidine for Sedation in Adult Intensive Care This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the
More informationIntravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial
306 ASTHMA Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial G Roberts, D Newsom, K Gomez, A Raffles, S Saglani, J Begent,
More informationGuideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use
Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document
More informationRespiratory system. Contents: 1. Asthma acute exacerbations
Respiratory system Medicines Formulary Contents: 1. Asthma acute exacerbations 1 2. Asthma chronic 4 3. Chronic obstructive pulmonary disease acute exacerbations 6 4. Chronic obstructive pulmonary disease
More informationI. Subject: Continuous Aerosolization of Bronchodilators
I. Subject: Continuous Aerosolization of Bronchodilators II. Indications: A. Acute airflow obstruction in which treatment with an aerosolized bronchodilator is desired for an extended period of time, i.e.
More informationAdministration of Short-Acting Beta-agonists for Acute Episodes of Moderate or Severe Asthma by Practice Nurses
1. Clinical Condition or situation to which this Patient Group Direction applies Definition of clinical condition/situation Adults and children aged 2 years and above presenting with increasing symptoms
More informationGuidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas aeruginosa Lung Infections in Adults
Index No: MMG41 Guidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas Version: 2 Date ratified: November 2017 Ratified by: (Name of Committee) Name of originator/author,
More informationCaution: This Guideline describes management of Acute Asthma in PICU.
Acute Asthma PICU Caution: This Guideline describes management of Acute Asthma in PICU. There is a separate guideline for the management of Acute Asthma within the General Ward/Pre-Critical Care setting,
More informationSouthern Trust Home IV Service. Guidelines for the administration of IV antibiotics
Southern Trust Home IV Service Guidelines for the administration of IV antibiotics Title: Author: CLINICAL GUIDELINES ID TAG Antibiotic guidelines - Southern Trust Home IV service guidelines for the administration
More informationAdult Dose. Adults Day 1: 1mg/kg daily Day 2: 2mg/kg daily Day 3 onwards: 3mg/kg daily. Where appropriate consider rounding dose to nearest 50mg.
AMIKACIN All ages>1month: 30mg/kg daily 1.5g once daily IV infusion over 30-60 Monitor renal function before treatment and weekly. Caution if used with other nephrotoxic drugs. Levels required. Trough
More informationpatient group direction
SALBUTAMOL v01 1/12 SALBUTAMOL PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner
More informationPost Event Report: Primary Care Regional Training Event for the Management of Children and Young People s Wheeze & Asthma
Post Event Report: Primary Care Regional Training Event for the Management of Children and Young People s Wheeze & Asthma 23 November 2016 1 Background Nationally there are Increasing numbers of Children
More informationGuideline for Management of Severe or Fulminating Pre-Eclampsia
Guideline for Management of Severe or Fulminating Pre-Eclampsia Originator: Labour Ward Forum, Maternity Services Date Approved: September 2011 Approved by: W&CH Quality & Safety Group Reviewed and ratified
More informationIndex No: MMG11/1. Version: 1. Date ratified: 12 th November 2013
Index No: Intravenous fluid prescription in children For previously well children aged one month to 16 years (excluding renal, cardiac, diabetic ketoacidosis and acute burns patients) Version: 1 Date ratified:
More informationASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides
BRONCHIAL ASTHMA ASTHMA Epidemiology Pathophysiology Diagnosis 2 CHILDHOOD ASTHMA Childhood bronchial asthma is characterized by Airway obstruction which is reversible Airway inflammation Airway hyper
More informationAsthma Care in the Emergency Department Clinical Practice Guideline
Asthma Care in the Emergency Department Clinical Practice Guideline Inclusion: 1) Children 2 years of age or older with a prior history of wheezing, and 2) Children less than 2 years of age with likely
More informationAntiallergics and drugs used in anaphylaxis
Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis The H 1 -receptor antagonists are generally referred to as antihistamines. They inhibit the wheal, pruritus, sneezing
More informationSupplementary Medications during asthma attack. Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus
Supplementary Medications during asthma attack Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus Conflicts of Interest None Definition of Asthma Airway narrowing that is
More informationThese guidelines have been developed by: Dr Peter Pereira, MBBS (UNSW), FACEM Director, Emergency Medicine, Cairns Base Hospital, Queensland.
Please refer to the following pages for the emergency management of the Irukandji Syndrome that has been developed through the Prevention and Response Working Group of the Irukandji Taskforce. These guidelines
More informationNguyen Tien Dung A/Prof. PhD. MD Head of Pediatric Department - Bach Mai Hospital
Nguyen Tien Dung A/Prof. PhD. MD Head of Pediatric Department - Bach Mai Hospital A girl patient 11 years old admitted to Bach mai Hospital at 4h15, 12nd November because of difficult breathing She has
More informationPatient Group Direction for SALBUTAMOL INHALER (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history
More informationSummary of Lothian Joint Formulary Amendments
Summary of Lothian Joint Formulary Amendments The purpose of this summary is to detail the main changes to the LJF sections and provide additional information on the reasons for some of the changes. The
More informationIDPH ESF-8 Plan: Pediatric and Neonatal Surge Annex Sample Pediatric Admission Orders 2015
Purpose: To provide guidance to practitioners caring for pediatric patients who need inpatient hospital care during a disaster. Disclaimer: This guideline is not meant to be all inclusive, replace an existing
More informationPACKAGE INSERT TEMPLATE FOR SALBUTAMOL TABLET & SALBUTAMOL SYRUP
PACKAGE INSERT TEMPLATE FOR SALBUTAMOL TABLET & SALBUTAMOL SYRUP Brand or Product Name [Product name] Tablet 2mg [Product name] Tablet 4mg [Product name] Syrup 2mg/5ml Name and Strength of Active Substance(s)
More informationSystemic Anti-Cancer Treatment (SACT) Hypersensitivity Guideline
This is an official Northern Trust policy and should not be edited in any way Systemic Anti-Cancer Treatment (SACT) Hypersensitivity Guideline Reference Number: NHSCT/12/518 Target audience: This document
More informationIt is recommended that a mask and protective eyewear be worn when providing care to a patient with a cough
UNIVERSITY HEALTH NETWORK POLICY #: PAGE 1 OF 7 POLICY AND PROCEDURE MANUAL: RESPIRATORY THERAPY DEPT PATIENT CARE SECTION ORIGINAL DATE: 04/03 ISSUED BY: SITE LEADER APPROVED BY: Infection Prevention
More informationCLINICAL GUIDELINES ID TAG
CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Guideline for the perioperative fluid management in children Kieran O Connor Anaesthetics ATICS Date Uploaded: 26/04/2016 Review
More informationBronchodilator Delivery and Nebuliser Trials in Adults
Bronchodilator Delivery and Nebuliser Trials in Adults Acute Management Favour the use of MDI (+/- Spacer) If considering nebuliser Short term treatment Approx. < 3 weeks See optimisation of inhaled bronchodilators
More informationChronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines
Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines Where appropriate the following should be offered before commencing inhaled treatment: Offer treatment and support to stop smoking. Smoking
More informationPHARMACOLOGICAL PROBLEMS
PHARMACOLOGICAL PROBLEMS 1. A 69 year old woman suffering from CHF has been treated with.25 mg Digoxin tablet daily for last 3 months. But the heart failure is not controlled adequately. What will be the
More informationGUIDANCE NOTES. DIETETIC RISK ASSESSMENT FOR REFEEDING RECOMMENDED MEAL PLANS When commencing re-feeding: NICE (2006)
When commencing re-feeding: NICE (2006) NICE (2006) Clinical Guideline 32 Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition (The following is based on www.nice.org.uk/cg032
More informationShared Care Guideline
Shared Care Guideline Gentamicin for Nebulisation For the long term prophylaxis of chronic lung infections in non CF bronchiectasis Executive Summary Indication Nebulised gentamicin is indicated in patients
More informationDRUG GUIDELINE. MAGNESIUM SULFATE (Obstetric)
DRUG GUIDELINE MAGNESIUM SULFATE (Obstetric) SCOPE (Area): FOR USE IN: Labour Ward, 5N, HDU, ED and Theatre EXCLUSIONS: Paediatrics (seek Paediatrician advice) and other General Wards SCOPE (Staff): Medical,
More informationCHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES Document Description Document Type Service Application Version Guidelines All healthcare professionals(hcps) caring for patients with asthma
More information3 RESPIRATORY SYSTEM
3 RESPIRATORY SYSTEM 3.01 ANTIASTHMATICS 3.01a BETA 2 AGONIST ASTHMA, CHRONIC BRONCHITIS & EMPHYSEMA Salbutamol Inhaler 100ug/dose [Albuterol] (Ventolin) Salbutamol Sulphate Respirator Solution 0.5% (5mg/ml),
More informationQuality Care Innovation lead clinician for integrated respiratory service georges ng* man kwong
Working in partnership Quality Care Innovation lead clinician for integrated respiratory service georges ng* man kwong chest physician pronounced ning qualified 1990 chief clinical information officer
More informationJoint Trust Guideline for the Management of Methylprednisolone Sodium Succinate Infusion for Child or Young Person A Clinical Guideline
A Clinical Guideline For Use in: Children s Department By: Registered Paediatric Nurses and Medical Staff Children with active inflammatory bowel disease, For: active rheumatological conditions or other
More informationMANAGEMENT OF AN ACUTE EPISODE OF ASTHMA IN CHILDREN
MANAGEMENT OF AN ACUTE EPISODE OF ASTHMA IN CHILDREN Dr. Ebor Jacob 1, Dr. Manivachagan 2, Dr. Amith Balachandran 3 1 Professor, 2 Associate Professor, Paediatric ICU, Christian Medical College, Vellore.
More informationVENTOLIN RESPIRATOR SOLUTION
VENTOLIN RESPIRATOR SOLUTION Salbutamol QUALITATIVE AND QUANTITATIVE COMPOSITION VENTOLIN Respirator Solution contains 5mg salbutamol, as sulphate, per ml of solution and is supplied in 10 ml bottles.
More informationN-Acetylcysteine Dosing Guidelines for Paracetamol Overdose in Adults
N-Acetylcysteine Dosing Guidelines for Paracetamol Overdose in Adults This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the
More informationPM-03 PED ALLERGY/ANAPHYLAXIS. Protocol SECTION: PM-03 PROTOCOL TITLE: PED ALLERGY/ANAPHYLAXIS REVISED: 01MAY2018
SECTION: PROTOCOL TITLE: REVISED: 01MAY2018 BLS SPECIFIC CARE: See General Pediatric Care Protocol PM-1 - Determine patient s color category on length based resuscitation tape (Broselow Tape) Epi Pen Protocol
More information